zoom_in Click to enlarge

WINLEVI (clascoterone) cream 1%

▲ ▼

language

description WINLEVI (clascoterone) cream 1% Overview

WINLEVI (clascoterone) cream 1% is a topical prescription medication approved for the treatment of acne vulgaris. It functions as a topical androgen receptor inhibitor, distinguishing its mechanism from traditional acne treatments like retinoids or antibiotics. By blocking androgen receptors locally in the sebaceous glands, it reduces sebum production and inflammation. It is intended for patients seeking a non-antibiotic approach to managing acne.

help WINLEVI (clascoterone) cream 1% FAQ

What is the active ingredient in WINLEVI cream?

WINLEVI contains clascoterone at a 1% concentration. Clascoterone is a topical androgen receptor inhibitor used for acne vulgaris.

Who is WINLEVI approved for?

The FDA indication covers acne vulgaris in patients aged 12 and older. It is a prescription medicine, so the prescribing clinician should determine whether it fits a particular person's skin and medical history.

How does WINLEVI differ from a retinoid or antibiotic cream?

WINLEVI targets androgen receptors in the skin rather than working as a retinoid or antibiotic. That gives it a different mechanism from common topical treatments such as tretinoin or benzoyl peroxide.

How was WINLEVI studied for acne?

The FDA label describes two randomized, vehicle-controlled trials in which 1,421 participants aged 12 and older applied WINLEVI or the vehicle twice daily for 12 weeks. The approved label, not a general skincare routine, should guide actual use.

swap_horiz

Looking for WINLEVI (clascoterone) cream 1% alternatives? Compare top competitors ranked & scored

arrow_forward